Home Excelencia Severo Ochoa

Advanced imaging at CNIC

Collaborations

CNIC has established strategic alliances essential for:

  • State-of-the-art training of CNIC scientific and technical personnel
  • Development of joint scientific programs with world leading institutions
  • Networking for the undertaking of large human studies
  • Internationalization of CNIC activities

All collaborations listed here have been institutionalized by the signature of official agreements.

Collaborating institution and field of collaboration:

  • Mount Sinai School of Medicine: NGI, Molecular Imaging
  • Mount Sinai School of Medicine: Heart Failure and Gene Therapy
  • Johns Hopkins U.: Epidemiology
  • Tufts U.: Human population genetics
  • Massachusetts General Hospital, Stem Cell Research Institute: New therapeutic approaches for heart repair
  • Copenhagen U.: Human cohort studies
  • Philips: NGI development
  • Hyperimage partners: NGI Development
  • Telomere Project: Epidemiology of telomere biology (agreement to be signed)

< PreviousNext >

PETTC

CNIC’s golden aim is to identify and prevent Cardiovascular disease (CVD) before individual’s health is impaired. To predict who is at high risk of CVD, understand the early steps of the disease and design new preventive strategies, CNIC has built 3 essential capabilities at distributed in 5500 m2 state-of-the-art facilities:

  • a) new generation imaging to detect early CVD
  • b) a long-term study on a large human population at risk, to trace CVD before symptoms appear
  • c) Preclinical research models to test the findings.